Jazz Makes Deal In Xyrem IP Fight With Ranbaxy, Sun, Ohm
Jazz Pharmaceuticals Inc. has agreed to drop its claims against generic-drug makers Ranbaxy, Sun and Ohm in a patent infringement case involving the narcolepsy drug Xyrem after the companies resolved their...To view the full article, register now.
Already a subscriber? Click here to view full article